Aberdeen Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$101M Buy
586,465
+30,827
+6% +$5.01M 0.34% 58
2017
Q1
$91.2M Buy
555,638
+14,034
+3% +$2.33M 0.32% 58
2016
Q4
$79.2M Buy
541,604
+65,803
+14% +$9.9M 0.3% 59
2016
Q3
$79.4M Sell
475,801
-1,220
-0.3% -$206K 0.28% 56
2016
Q2
$72.6M Buy
477,021
+18,446
+4% +$2.87M 0.27% 59
2016
Q1
$68.8M Sell
458,575
-463
-0.1% -$68.8K 0.25% 65
2015
Q4
$69.9M Buy
459,038
+23,959
+6% +$3.77M 0.24% 63
2015
Q3
$60.2M Buy
435,079
+11
+0% +$1.73K 0.21% 71
2015
Q2
$66.8M Buy
435,068
+43,338
+11% +$6.94M 0.19% 73
2015
Q1
$62.6M Buy
391,730
+104,492
+36% +$16.5M 0.17% 76
2014
Q4
$45.8M Sell
287,238
-81,053
-22% -$12.6M 0.11% 98
2014
Q3
$51.7M Sell
368,291
-18,877
-5% -$2.46M 0.11% 106
2014
Q2
$45.8M Buy
387,168
+308,087
+390% +$35.7M 0.1% 129
2014
Q1
$9.76M Sell
79,081
-299
-0.4% -$36.3K 0.03% 126
2013
Q4
$8.99M Hold
79,380
0.03% 131
2013
Q3
$8.89M Sell
79,380
-5,700
-7% -$618K 0.03% 123
2013
Q2
$8.39M Buy
+85,080
New +$8.83M 0.03% 122

Other funds holding AMGN

Aberdeen Asset Management's AMGN Position: Q2 2017 in Review

Aberdeen Asset Management increased its Amgen (AMGN) stake by 5.5% in Q2 2017, buying an estimated $5.01M and bringing the position to 586,465 shares worth $101M. The position accounts for 0.34% of the portfolio, ranked #58.

Aberdeen Asset Management first reported a position in AMGN in Q2 2013 and has held it in 17 quarters since. 1,596 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Aberdeen Asset Management held 586,465 shares of Amgen worth $101M as of Q2 2017.
  • Aberdeen Asset Management bought 30,827 Amgen shares in Q2 2017, an estimated $5.01M.
  • Amgen made up 0.34% of Aberdeen Asset Management's portfolio in Q2 2017, its #58 holding.
  • Aberdeen Asset Management first reported a position in Amgen in Q2 2013 and has held it in 17 quarters since.
  • 1,596 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.